The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells

Journal of Nutritional Biochemistry

Volumn 22, Issue 6, 2011, Pages 585-594

  Wu, Chi Hao ^a   Huang, Hsiao Wen ^a   Lin, Jer An ^a   Huang, Shang Ming ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end products; Caffeic acid; Inflammation; Methylglyoxal; Oxidative stress; Pro glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; CAFFEIC ACID; CHLOROGENIC ACID; COUMARIC ACID; EDETIC ACID; FERULIC ACID; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; METHYLGLYOXAL; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; DNA DAMAGE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; VASCULAR ENDOTHELIUM;

ANIMALS; CAFFEIC ACIDS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MONOCYTES; OXIDATIVE STRESS;

BOVINAE;

EID: 79955856266     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.05.002     Document Type: Article

References (34)

1. Sugimoto K., Yasujima M., Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 2008, 14:953-961.
2. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., et al. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008, 57:1002-1017.
3. Coughlan M.T., Mibus A.L., Forbes J.M. Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 2008, 1126:190-193.
4. Noordzij M.J., Lefrandt J.D., Smit A.J. Advanced glycation end products in renal failure: an overview. J Ren Care 2008, 34:207-212.
5. Hammes H.P., Alt A., Niwa T., Clausen J.T., Bretzel R.G., Brownlee M., et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 1999, 42:728-736.
6. Yamagishi S., Ueda S., Matsui T., Nakamura K., Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008, 14:962-968.
7. Basta G., Schmidt A.M., De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004, 63:582-592.
8. Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605.
9. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
10. Abu-Amsha R., Croft K.D., Puddey I.B., Proudfoot J.M., Beilin L.J. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci 1996, 91:449-458.
11. Yamanaka N., Oda O., Nagao S. Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. FEBS Lett 1997, 405:186-190.
12. Bhat S.H., Azmi A.S., Hadi S.M. Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: involvement of endogenous copper and a putative mechanism for anticancer properties. Toxicol Appl Pharmacol 2007, 218:249-255.
13. Zheng L.F., Dai F., Zhou B., Yang L., Liu Z.L. Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship. Food Chem Toxicol 2008, 46:149-156.
14. Wu C.H., Yen G.C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 2005, 53:3167-3173.
15. Wu C.H., Wu C.F., Huang H.W., Jao Y.C., Yen G.C. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol Nutr Food Res 2009, 53:984-995.
16. Wu C.H., Hsieh C.L., Song T.Y., Yen G.C. Inhibitory effects of Cassia tora L. on benzo[a]pyrene-mediated DNA damage toward HepG2 cells. J Agric Food Chem 2001, 49:2579-2586.
17. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
18. Nakamura Y., Horii Y., Nishino T., Shiiki H., Sakaguchi Y., Kagoshima T., et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 1993, 143:1649-1656.
19. Sims T.J., Rasmussen L.M., Oxlund H., Bailey A.J. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996, 39:946-951.
20. Huang S.M., Chuang H.C., Wu C.H., Yen G.C. Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells. Mol Nutr Food Res 2008, 52:940-949.
21. Karakaya S. Bioavailability of phenolic compounds. Crit Rev Food Sci Nutr 2004, 44:453-464.
22. Shih P.H., Chan Y.C., Liao J.W., Wang M.F., Yen G.C. Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. J Nutr Biochem 2009, (In press).
23. Yeh C.T., Ching L.C., Yen G.C. Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. J Nutr Biochem 2009, 20:163-171.
24. Goldwasser P., Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997, 50:693-703.
25. Shaklai N., Garlick R.L., Bunn H.F. Non enzymic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984, 259:3812-3817.
26. Woodside J.V., Yarnell J.W.G., McMaster D., Young I.S., Harmon D.L., McCrum E.E., et al. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemiaa double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr 1998, 67:858-866.
27. Lee Y.S., Kang Y.H., Jung J.Y., Lee S., Ohuchi K., Shin K.H., et al. Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull 2008, 31:1968-1972.
28. Sakihama Y., Cohen M.F., Grace S.C., Yamasaki H. Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants. Toxicology 2002, 177:67-80.
29. Klein R.L., Laimins M., Lopes-Virella M.F. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 1995, 44:1093-1098.
30. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell 2001, 104:503-516.
31. Sandu O., Song K., Cai W., Zheng F., Uribarri J., Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005, 54:2314-2319.
32. Yamabe N., Kang K.S., Park C.H., Tanaka T., Yokozawa T. 7-O-galloyl-D-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol Pharm Bull 2009, 32:657-664.
33. Gupta A., Tripathi A.K., Tripathi R.L., Madhu S.V., Banerjee B.D. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys 2007, 44:373-378.
34. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 2009, 26:1001-1043.